Evastin Tablets 10/20 mg
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Taeguk Pharmaceutical Co., Ltd.
MFDS item code 201903091 · Approved 2019.05.13
This product's status changed to Expired on 2024.05.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
This medication is used as an adjunct to dietary therapy for lowering high total cholesterol, LDL cholesterol, Apo B protein, and triglycerides in patients with primary hypercholesterolemia, especially heterozygous familial and non-familial, and mixed hyperlipidemia, as well as for increasing HDL cholesterol, the 'good' cholesterol. It can also be given alone to patients with homozygous familial hypercholesterolemia when other lipid-lowering therapies are not effective or cannot be used. This medication is used together with an appropriate diet that includes restrictions on saturated fats and cholesterol, and is prescribed when diet alone or non-drug measures are insufficient. Prior to treatment, secondary causes of hypercholesterolemia, such as diabetes or hypothyroidism, should be evaluated and treated as necessary. Regular monitoring of total cholesterol, LDL, HDL, and triglyceride levels is important to assess treatment progress. This medication helps reduce the risk of atherosclerotic vascular disease due to hypercholesterolemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, without regard to meals. Patients with primary hypercholesterolemia The dose range of this drug is 10/10mg to 10/40mg once daily. The usual recommended initial dose is 10/20mg once daily. For patients requiring less LDL cholesterol reduction, treatment may be initiated at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels after an interval of 4 weeks or longer and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have taken 10/80 mg of this drug for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this drug once daily in the evening. Use caution and monitor closely when administering higher doses of this drug to these patients (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after a bile acid sequestrant. Patients receiving verapamil, diltiazem, or dronedarone concomitantly with this drug should not exceed a dose of 10/10mg/day of this drug. Patients receiving amiodarone, amlodipine, or ranolazine concomitantly with this drug should not exceed a dose of 10/20mg/day of this drug.
This medication may cause muscle adverse reactions, so if muscle pain or weakness occurs, it should be reported to a physician immediately. This medication should not be used in patients with poor liver function, liver disease, or in pregnant or nursing women. Additionally, taking this medication with certain other medicines may increase the risk of muscle damage, so it is essential to inform the doctor of any other medications being taken. Elderly patients or those with certain myopathies need to exercise extra caution when using this medication. During treatment, it is advisable to regularly check blood tests to monitor muscle and liver conditions. If there are unexplained muscle pain, tenderness, or weakness while taking this medication, it should be stopped immediately and consult a healthcare professional. This medication should not be used in women who are planning to become pregnant or who may be pregnant, and it should be discontinued immediately upon confirmation of pregnancy. Women who are nursing should also be advised to stop breastfeeding while taking this medication. There is insufficient evidence of safety and efficacy for use in children and adolescents, so it should be used with caution. There is no specific antidote for overdose, but appropriate treatment should be provided based on symptoms.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, storing the medication at room temperature between 1°C and 30°C will maintain its efficacy.
White to off-white, biconvex, rectangular tablets
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Taeguk Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.